3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients

OBJECTIVES/SPECIFIC AIMS: In this study, we aim to describe temporal trends in opioid abuse among adolescents and 11-21years and young adults 22-35years with Sickle cell disease hospitalized for sickle cell crisis. We also aim to evaluate clinical and healthcare utilization outcomes of opioid abuse...

Full description

Bibliographic Details
Main Authors: Nnaemeka E Onyeakusi, Adebamike Oshunbade, Fahad Mukhtar, Adeyinka Adejumo, Semiu Gbadamosi, Chinonso Onwudiwe
Format: Article
Language:English
Published: Cambridge University Press 2019-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866119001304/type/journal_article
_version_ 1811156638990598144
author Nnaemeka E Onyeakusi
Adebamike Oshunbade
Fahad Mukhtar
Adeyinka Adejumo
Semiu Gbadamosi
Chinonso Onwudiwe
author_facet Nnaemeka E Onyeakusi
Adebamike Oshunbade
Fahad Mukhtar
Adeyinka Adejumo
Semiu Gbadamosi
Chinonso Onwudiwe
author_sort Nnaemeka E Onyeakusi
collection DOAJ
description OBJECTIVES/SPECIFIC AIMS: In this study, we aim to describe temporal trends in opioid abuse among adolescents and 11-21years and young adults 22-35years with Sickle cell disease hospitalized for sickle cell crisis. We also aim to evaluate clinical and healthcare utilization outcomes of opioid abuse in the same population. In addition, we hope to assess for difference in effect by age category. METHODS/STUDY POPULATION: Our study is a cross-sectional study of data secondarily sourced from the 2007-2014 National Inpatient Sample(NIS), a component of the Healthcare Utilization Project (HCUP). Variables were identified using ICD-9-CM codes. We selected inpatient stays for patients aged 11-35 years admitted for sickle cell crisis. Opioid abuse was the primary outcome of interest. Secondary outcomes were inpatient mortality, total charge, length of stay and select clinical outcomes. We analyzed our data for trends and outcomes. We performed trend analysis of prevalence rates between 2007-2014 by age categories. Propensity-Matched Score regression models were deployed to assess for associations between opioid abuse and outcomes while adjusting for relevant covariates. Sub-group analysis of opioid abuse by age was assessed for outcomes of interest. Trend analysis was performed on Joinpoint Software v4.6.0, (National Cancer Institute, NIH, Bethesda, MD). Outcome analysis was performed on SAS v9.4 (SAS Institute, Cary, NC). Statistical significance was set at 95% and p-value of 0.05, two-tailed. RESULTS/ANTICIPATED RESULTS: Of 86,827 inpatients admitted for sickle cell crisis, 2,363 (2.73%) had a diagnosis of opioid abuse while 84,464 (97.27%)did not abuse opioids. 27,004 (31.01%) of admitted patients were 11-21 years while 59,823 (68.99%) were 21-35 years. We found statistically significant APCs (Annual Percentage Change) showing increasing trends in both age categories for years under review, (18.47% [95% CI 15.39-21.63]; p-value <0.001 in young adults vs. 10.31% [95% CI 3.58-17.49]; p-value 0.009 in adolescents). The difference in APCs between both age categories were also significant (−8.16% [95% CI [−14.26-2.05]; p-value 0.009). There were no parallelism or coincidence in the trend lines. Opioid abuse was found to be associated with significantly longer length of stay (7.74 vs 6.05 days), higher total charge ($40,797 vs $32,164), (aOR 1.44; 95% CI [1.19-1.75]) seizures, sepsis (aOR 1.62; 95% CI [1.35-1.94]) and pulmonary hypertension (aOR 1.36; 95% CI [1.12-1.66]). No significant association was found for inpatient mortality, transfusion, cardiac dysrhythmias, pulmonary embolism and acute kidney injury. Significant interaction existed between opioid abuse and age for total charge (for $41,869 vs $29,371 among adolescents & $40,632 vs $32,550 among young adults; interaction p-value 0.03). DISCUSSION/SIGNIFICANCE OF IMPACT: Trends show a significant increase in the prevalence of opioid abuse among adolescents and an increasingly higher prevalence when adolescents transition to young adults. Opioid abuse among sickle cell patients is associated with significant poor healthcare resource utilization and clinical outcomes. Public health interventions to prevent worsening opioid abuse prevalence are expected to improve patient outcomes.
first_indexed 2024-04-10T04:53:38Z
format Article
id doaj.art-5c2b84e82c6a4ce89d6fc8cf00b91c2b
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:53:38Z
publishDate 2019-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-5c2b84e82c6a4ce89d6fc8cf00b91c2b2023-03-09T12:30:30ZengCambridge University PressJournal of Clinical and Translational Science2059-86612019-03-013545510.1017/cts.2019.1303458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease PatientsNnaemeka E Onyeakusi0Adebamike Oshunbade1Fahad Mukhtar2Adeyinka Adejumo3Semiu Gbadamosi4Chinonso Onwudiwe5BronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLBronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLBronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLBronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLBronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLBronxCare Hospital Center, Bronx, NY; St. Elizabeth’s HospitalWashington, DC; North Shore Medical Center, Salem, MA; Florida International University, Miami, FLOBJECTIVES/SPECIFIC AIMS: In this study, we aim to describe temporal trends in opioid abuse among adolescents and 11-21years and young adults 22-35years with Sickle cell disease hospitalized for sickle cell crisis. We also aim to evaluate clinical and healthcare utilization outcomes of opioid abuse in the same population. In addition, we hope to assess for difference in effect by age category. METHODS/STUDY POPULATION: Our study is a cross-sectional study of data secondarily sourced from the 2007-2014 National Inpatient Sample(NIS), a component of the Healthcare Utilization Project (HCUP). Variables were identified using ICD-9-CM codes. We selected inpatient stays for patients aged 11-35 years admitted for sickle cell crisis. Opioid abuse was the primary outcome of interest. Secondary outcomes were inpatient mortality, total charge, length of stay and select clinical outcomes. We analyzed our data for trends and outcomes. We performed trend analysis of prevalence rates between 2007-2014 by age categories. Propensity-Matched Score regression models were deployed to assess for associations between opioid abuse and outcomes while adjusting for relevant covariates. Sub-group analysis of opioid abuse by age was assessed for outcomes of interest. Trend analysis was performed on Joinpoint Software v4.6.0, (National Cancer Institute, NIH, Bethesda, MD). Outcome analysis was performed on SAS v9.4 (SAS Institute, Cary, NC). Statistical significance was set at 95% and p-value of 0.05, two-tailed. RESULTS/ANTICIPATED RESULTS: Of 86,827 inpatients admitted for sickle cell crisis, 2,363 (2.73%) had a diagnosis of opioid abuse while 84,464 (97.27%)did not abuse opioids. 27,004 (31.01%) of admitted patients were 11-21 years while 59,823 (68.99%) were 21-35 years. We found statistically significant APCs (Annual Percentage Change) showing increasing trends in both age categories for years under review, (18.47% [95% CI 15.39-21.63]; p-value <0.001 in young adults vs. 10.31% [95% CI 3.58-17.49]; p-value 0.009 in adolescents). The difference in APCs between both age categories were also significant (−8.16% [95% CI [−14.26-2.05]; p-value 0.009). There were no parallelism or coincidence in the trend lines. Opioid abuse was found to be associated with significantly longer length of stay (7.74 vs 6.05 days), higher total charge ($40,797 vs $32,164), (aOR 1.44; 95% CI [1.19-1.75]) seizures, sepsis (aOR 1.62; 95% CI [1.35-1.94]) and pulmonary hypertension (aOR 1.36; 95% CI [1.12-1.66]). No significant association was found for inpatient mortality, transfusion, cardiac dysrhythmias, pulmonary embolism and acute kidney injury. Significant interaction existed between opioid abuse and age for total charge (for $41,869 vs $29,371 among adolescents & $40,632 vs $32,550 among young adults; interaction p-value 0.03). DISCUSSION/SIGNIFICANCE OF IMPACT: Trends show a significant increase in the prevalence of opioid abuse among adolescents and an increasingly higher prevalence when adolescents transition to young adults. Opioid abuse among sickle cell patients is associated with significant poor healthcare resource utilization and clinical outcomes. Public health interventions to prevent worsening opioid abuse prevalence are expected to improve patient outcomes.https://www.cambridge.org/core/product/identifier/S2059866119001304/type/journal_article
spellingShingle Nnaemeka E Onyeakusi
Adebamike Oshunbade
Fahad Mukhtar
Adeyinka Adejumo
Semiu Gbadamosi
Chinonso Onwudiwe
3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
Journal of Clinical and Translational Science
title 3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
title_full 3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
title_fullStr 3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
title_full_unstemmed 3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
title_short 3458 Temporal Trends and Outcomes of Opioid Abuse among Adolescents & Young Adult Sickle Cell Disease Patients
title_sort 3458 temporal trends and outcomes of opioid abuse among adolescents young adult sickle cell disease patients
url https://www.cambridge.org/core/product/identifier/S2059866119001304/type/journal_article
work_keys_str_mv AT nnaemekaeonyeakusi 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients
AT adebamikeoshunbade 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients
AT fahadmukhtar 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients
AT adeyinkaadejumo 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients
AT semiugbadamosi 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients
AT chinonsoonwudiwe 3458temporaltrendsandoutcomesofopioidabuseamongadolescentsyoungadultsicklecelldiseasepatients